Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 869

1.

Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.

Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM.

Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):256-62.

PMID:
23742770
2.

A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.

Poon KS, Chen TH, Jeng LB, Yang HR, Li PC, Lee CC, Yeh CC, Lai HC, Su WP, Peng CY, Chen YF, Ho YJ, Tsai PP.

Transplant Proc. 2012 Mar;44(2):316-9. doi: 10.1016/j.transproceed.2012.02.006.

PMID:
22410005
3.
4.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

5.

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.

6.

Which score system can best predict recipient outcomes after living donor liver transplantation?

Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK.

Transplant Proc. 2012 Mar;44(2):393-5. doi: 10.1016/j.transproceed.2012.01.064.

PMID:
22410025
7.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

8.

Impact of MELD score implementation on liver allocation: experience at a Brazilian center.

da Silva Machado AG, de Medeiros Fleck A Jr, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.

Ann Hepatol. 2013 May-Jun;12(3):440-7.

9.

Live donor liver transplantation in high MELD score recipients.

Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.

Ann Surg. 2010 Jan;251(1):153-7. doi: 10.1097/SLA.0b013e3181bc9c6a.

PMID:
19858705
10.

Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.

Wai CT, Woon WA, Tan YM, Lee KH, Tan KC.

Transplant Proc. 2012 Mar;44(2):396-8. doi: 10.1016/j.transproceed.2012.01.030.

PMID:
22410026
11.

Does model for end-stage liver disease score predict the short-term outcome of living donor liver transplantation?

Li C, Wen T, Yan L, Li B, Wang W, Xu M, Yang J, Wei Y.

Transplant Proc. 2010 Nov;42(9):3620-3. doi: 10.1016/j.transproceed.2010.07.100.

PMID:
21094827
12.

Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.

Chok KS, Fung JY, Chan AC, Dai WC, Sharr WW, Cheung TT, Chan SC, Lo CM.

Ann Surg. 2017 Jan;265(1):173-177. doi: 10.1097/SLA.0000000000001671.

PMID:
28009743
13.

High model for end-stage liver disease score as a predictor of survival during long-term follow-up after liver transplantation.

Suzuki H, Bartlett AS, Muiesan P, Jassem W, Rela M, Heaton N.

Transplant Proc. 2012 Mar;44(2):384-8. doi: 10.1016/j.transproceed.2011.11.013.

PMID:
22410023
14.

Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.

Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, Hernandez-Alejandro R.

Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115.

PMID:
22664005
15.

D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.

Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.

Transplantation. 2014 Feb 27;97(4):457-62. doi: 10.1097/01.TP.0000435696.23525.d0.

PMID:
24531822
16.

Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience.

Umgelter A, Lange K, Kornberg A, Büchler P, Friess H, Schmid RM.

Transplant Proc. 2011 Dec;43(10):3762-8. doi: 10.1016/j.transproceed.2011.08.110.

PMID:
22172843
17.

Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.

Lai YH, Duan WD, Yu Q, Ye S, Xiao NJ, Zhang DX, Huang ZQ, Yang ZY, Dong JH.

World J Gastroenterol. 2015 May 28;21(20):6296-303. doi: 10.3748/wjg.v21.i20.6296.

18.

Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.

Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J.

Surg Today. 2013 Sep;43(9):1039-48. doi: 10.1007/s00595-013-0539-z. Epub 2013 Mar 7.

PMID:
23467980
19.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
20.

Using a small-for-size graft might attribute to the future use of left-lobe living graft in adult to adult living donor liver transplantation.

Li HY, Wei YG, Yan LN, Wen TF, Zhao JC, Xu MQ, Wang WT, Yang JY.

Hepatogastroenterology. 2012 Oct;59(119):2050-3.

PMID:
22640916

Supplemental Content

Support Center